Literature DB >> 9885222

Functional role of interleukin-4 (IL-4) and IL-7 in the development of X-linked severe combined immunodeficiency.

S Kumaki1, N Ishii, M Minegishi, S Tsuchiya, D Cosman, K Sugamura, T Konno.   

Abstract

X-linked severe combined immunodeficiency (X-SCID) is characterized by an absent or diminished number of T cells and natural-killer (NK) cells with a normal or elevated number of B cells, and results from mutations of the gammac chain. The gammac chain is shared by interleukin-2 (IL-2), IL-4, IL-7, IL-9, and IL-15 receptors. Recently, a survival signal through the IL-7 receptor alpha (IL-7Ralpha) chain was shown to be important for T-cell development in mice and was suggested to contribute to the X-SCID phenotype. In the present study, we examined function of a mutant gammac chain (A156V) isolated from an X-SCID patient and found that T cells expressing the mutant gammac chain were selectively impaired in their responses to IL-4 or IL-7 compared with the wild-type gammac chain expressing cells although responses to IL-2 or IL-15 were relatively maintained. The result shows that IL-4- and/or IL-7-induced signaling through the gammac chain is critical for T-cell development and plays an important role in the development of the X-SCID phenotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9885222

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Primary T-lymphocyte immunodeficiencies.

Authors:  A Fischer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 2.  Severe combined immunodeficiencies (SCID).

Authors:  A Fischer
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

3.  Characterization of a novel nonsense mutation in the interleukin-7 receptor alpha gene in a Korean patient with severe combined immunodeficiency.

Authors:  Eun-Kyeong Jo; Hoon Kook; Toru Uchiyama; Ikuko Hakozaki; Young-Ok Kim; Chang-Hwa Song; Jeong-kyu Park; Hirokazu Kanegane; Shigeru Tsuchiya; Satoru Kumaki
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

4.  Alternative Splicing Rescues Loss of Common Gamma Chain Function and Results in IL-21R-like Deficiency.

Authors:  David Illig; Marta Navratil; Jadranka Kelečić; Raffaele Conca; Iva Hojsak; Oleg Jadrešin; Marijana Ćorić; Jurica Vuković; Meino Rohlfs; Sebastian Hollizeck; Jens Bohne; Christoph Klein; Daniel Kotlarz
Journal:  J Clin Immunol       Date:  2019-03-21       Impact factor: 8.317

Review 5.  Inborn errors of the development of human natural killer cells.

Authors:  Emmanuelle Jouanguy; Laure Gineau; Julien Cottineau; Vivien Béziat; Eric Vivier; Jean-Laurent Casanova
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-12

6.  Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency.

Authors:  Valentina Poletti; Sabine Charrier; Guillaume Corre; Bernard Gjata; Alban Vignaud; Fang Zhang; Michael Rothe; Axel Schambach; H Bobby Gaspar; Adrian J Thrasher; Fulvio Mavilio
Journal:  Mol Ther Methods Clin Dev       Date:  2018-03-10       Impact factor: 6.698

7.  Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency.

Authors:  Susannah I Thornhill; Axel Schambach; Steven J Howe; Meera Ulaganathan; Elke Grassman; David Williams; Bernhard Schiedlmeier; Neil J Sebire; H Bobby Gaspar; Christine Kinnon; Christopher Baum; Adrian J Thrasher
Journal:  Mol Ther       Date:  2008-01-08       Impact factor: 11.454

8.  Cell type differences in activity of the Streptomyces bacteriophage phiC31 integrase.

Authors:  Christof Maucksch; Manish Kumar Aneja; Elisabeth Hennen; Alexander Bohla; Florian Hoffmann; Markus Elfinger; Joseph Rosenecker; Carsten Rudolph
Journal:  Nucleic Acids Res       Date:  2008-08-21       Impact factor: 16.971

9.  A new phenylpyrazoleanilide, y-320, inhibits interleukin 17 production and ameliorates collagen-induced arthritis in mice and cynomolgus monkeys.

Authors:  Hiroyuki Ushio; Seigo Ishibuchi; Koichi Oshita; Noriyasu Seki; Hirotoshi Kataoka; Kunio Sugahara; Kunitomo Adachi; Kenji Chiba
Journal:  Pharmaceuticals (Basel)       Date:  2013-12-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.